Product & Service Code Classification
PSC AN11: R&D - Biomedical: mRNA Vaccines and Therapeutic Platforms
Official procurement records and prime contractor award distribution for federal Product & Service Code (PSC) AN11: R&D - Biomedical: mRNA Vaccines and Therapeutic Platforms.
PSC Category Overview
Verified SAM.gov & FPDS DataFederal procurement spending under Product & Service Code (PSC) AN11 (R&D - Biomedical: mRNA Vaccines and Therapeutic Platforms) reached $21.80B across 1,418 registered vendors. Small businesses capture 26.5% of total obligations, with an average award size of $5.2M.
•Annual Obligations: $21.80B
•Vendor Pool: 1,418 contractors
•Small Business Share: 26.5%
•Average Award Size: $5.2M
Annual Spend
$21.80B
Obligated in fiscal year
Small Business Share
26.5%
Socioeconomic programs
Active Vendors
1,418
Prime contract holders
Average Award Size
$5.2M
Mean task order value
Top Prime Contractors for PSC AN11
| Contractor Name | Annual Spend Capture | Market Share % | Action |
|---|---|---|---|
| Booz Allen Hamilton Inc. | $2.40B | 11.0% | View Profile |
| Lockheed Martin Corporation | $3.49B | 16.0% | View Profile |
| Leidos Holdings, Inc. | $1.96B | 9.0% | View Profile |
Agency Breakdown for PSC AN11
DoD
Department of Defense
View agency procurement history
USA
Department of the Army
View agency procurement history
USN
Department of the Navy
View agency procurement history
USAF
Department of the Air Force
View agency procurement history
DHA
Defense Health Agency
View agency procurement history
VA
Department of Veterans Affairs
View agency procurement history